RecruitingNCT05554835

Global Registry and Natural History Study for Mitochondrial Disorders

Global Mitochondrial Registry to Define Natural History and Outcome Measures to Achieve Definite Trial Readiness for Mitochondrial Disorders

Sponsor

LMU Klinikum

Enrollment

6,000 participants

Start Date

Feb 1, 2009

Study Type

OBSERVATIONAL

Conditions

MDS NARP Syndrome Mitochondrial Diseases MELAS Syndrome Kearns-Sayre Syndrome MIDD SANDO SCAE MERRF Syndrome Coenzyme Q10 Deficiency LHON MNGIE MIRAS Barth Syndrome

Summary

The main goal of the project is provision of a global registry for mitochondrial disorders to harmonize previous national registries, enable world-wide participation and facilitate natural history studies, definition of outcome measures and conduction of clinical trials.

Eligibility

Inclusion Criteria2

suspected or confirmed mitochondrial disease
willingness to participate

Exclusion Criteria1

unwillingness to participate

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(18)

Medical University Innsbruck, Department of Pediatrics

Innsbruck, Austria

Salzburger Landeskliniken, SALK, Paracelsus Medizinische Privatuniversität

Salzburg, Austria

Department of neurology, Klinikum rechts der Isar, Technical University Munich

Munich, Bavaria, Germany

Charité Virchow Klinikum, Klinik für Pädiatrie m. S. Neurologie

Berlin, Germany

Universität Bonn, Klinik und Poliklinik für Neurologie

Bonn, Germany

Universitätsklinikum Köln, Klinik und Poliklinik für Kinder- und Jugendmedizin

Cologne, Germany

Universitätsklinikum Düsseldorf, Klinik für allgemeine Pädiatrie, Neonatologie und Kinderkardiologie

Düsseldorf, Germany

Universitätsklinikum Frankfurt, Klinik für Kinder- und Jugendmedizin, Schwerpunkt Neurologie, Neurometabolik und Prävention

Frankfurt am Main, Germany

University Medical Center Freiburg, Center for children and youth medicine

Freiburg im Breisgau, Germany

Martin-Luther-Universität Halle-Wittenberg, Neurologische Klinik und Poliklinik

Halle, Germany

Universitätsklinikum Hamburg Eppendorf Institut für Humangenetik

Hamburg, Germany

Universitätsklinikum Hamburg Eppendorf, Klinik für Kinder-und Jugendmedizin

Hamburg, Germany

Universitätsklinikum Hamburg Eppendorf, Klinik für Neurologie

Hamburg, Germany

Universitätsklinikum Heidelberg, Zentrum für Kinder- und Jugendmedizin, Sektion für Neuropädiatrie und Stoffwechselmedizin

Heidelberg, Germany

LMU Klinikum, Friedrich-Baur-Institut an der Neurologischen Klinik und Poliklinik

München, Germany

Klinikum am Steinenberg, Kreiskliniken Reutlingen, Klinik für Kinder-und Jugendmedizin, Perinatal- u. Stoffwechselzentrum

Reutlingen, Germany

Universitätsklinikum Tübingen, Neurologische Klinik und Hertie Institut für Klinische Hirnforschung

Tübingen, Germany

Department of Clinical and Experimental Medicine, Neurological Institute, University of Pisa & AOUP

Pisa, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05554835

Related Trials

Replacing Bone Marrow Diagnostics With Peripheral Blood Analysis in Cytopenia Patients

NCT070810872 locations

Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

NCT018611061 location

A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies

NCT057965702 locations

Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

NCT046440161 location

Study Evaluating Combination of Luspatercept in LR-MDS Without RS Having Failed or Being Ineligible to ESA

NCT0518173540 locations